"An independent, dedicated clinical research site, dedicated to the development of safe, effective and novel therapies for patients."

During the past decade, Research by Design, LLC conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 13 clinical trials were completed, i.e. on average, 65% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 8 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Research by Design, LLC" #1 sponsor was "Pfizer" with 6 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "OPKO Health, Inc." with 3 trials sponsored, "Bayer" with 2 trials sponsored and "Abbott" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Research by Design, LLC" #1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Cyclerion Therapeutics" with 1 trials as a collaborator, "Harvard University" with 1 trials as a collaborator, "Massachusetts General Hospital" with 1 trials as a collaborator and "Worldwide Clinical Trials" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Research by Design, LLC" are "Chronic Kidney Disease" (5 trials), "Diabetic Nephropathies" (4 trials), "Chronic Renal Failure" (3 trials), "Diabetic Kidney Disease" (3 trials) and "COVID-19" (2 trials). Many other conditions were trialed in "Research by Design, LLC" in a lesser frequency.

Most popular intervention types in "Research by Design, LLC" are "Drug" (26 trials), "Biological" (3 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "BI 685509" (3 trials), "Epoetin Hospira" (3 trials), "CTAP101 Capsules" (2 trials) and "Calcifediol Oral Capsule" (2 trials). Other intervention names were less common.

The vast majority of trials in "Research by Design, LLC" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Research by Design, LLC". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Research by Design, LLC, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Research by Design, LLC, 5 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".